FDA Adverse Event Monitoring System (AEMS)

US FDA adverse-event monitoring infrastructure for regulated products. Psychedelic relevance: FDA has issued draft clinical trial guidance for psychedelic drugs and AEMS is the active public safety-monitoring surface.